Our laboratory found that tumor-derived Shh ligand promotes PD-L1 expression on TAMs in a mouse hepatocellular carcinoma model and higher expression of PD-L1 results in suppressed production of IFN-γ and granzyme-B in CD8+ TILs [27]. This evidence concerns the gene CD8A and neoplasm.